Cardiovascular medicine

Key highlights from Heart Failure 2024 – Annual congress of the Heart Failure Association of the ESC

8 August 2024

Professor Paul Kalra summarises key findings presented at the 2024 Heart Failure Association ESC meeting in Lisbon. He discusses the new data on hypertrophic cardiomyopathy, heart failure with reduced ejection fraction, and challenges in diagnosis and treatment optimisation. He also explores the early benefits of sodium-glucose co-transporter 2 inhibitors and evidence-based treatments for heart failure with preserved ejection fraction.

Harmonising the guidelines: making sense of lipid treatment advice

23 July 2024

Watch Terry McCormack and Rani Khatib discuss the updates to lipid management guidelines to reduce the risk of cardiovascular disease and implications for clinical practice. They will provide an overview of which patients should be treated, outline the current lipid-lowering targets and introduce the range of suitable treatments.

Sport and the heart

27 June 2024

Many of us understand the importance of exercise to improve not only our cardiovascular health, but health in general. Despite healthier living, cardiac-related injury or even death can occur in those who appear physically healthy, even athletes. Join Dr Gherardo Finocchiaro as he discusses the aetiology and epidemiology of sudden cardiac death, and the importance of cardiac screening, diagnosis and risk minimisation.

Looking forward to ESC 2024

4 June 2024

Join Professor John McMurray as he highlights some of the must-see sessions at the upcoming ESC Congress 2024 in London. Do not miss out on this unique opportunity to advance your knowledge and network with leading experts in cardiology.

The COVID-19 cardiovascular legacy: long COVID and its complications

30 April 2024

COVID-19, and specifically long COVID, is associated with an increased risk of cardiovascular disease. Listen as Professor Banerjee describes his work in this area, especially the STIMULATE-ICP trial, which looks at long COVID’s physiological and social impact. Find out about what the NHS is doing to tackle COVID-19 and its associated cardiovascular and metabolic abnormalities.

25in25 – preventing unnecessary deaths due to heart failure

4 April 2024

Heart failure prevalence is increasing in the UK, requiring long-term strategies. Join Lisa Anderson and Janine Hogan from the British Society for Heart Failure to see how a new initiative – 25in25 – aims to tackle this challenge.